Cited by 31Pancreatic function and diabetesPluripotent Stem Cells ResearchDiabetes and associated disorders

Stem cells and pancreatic differentiation in vitro

Blyszczuk, Przemyslaw, Wobus, Anna M.·2004·Journal of Biotechnology

Abstract

Cell therapy using pancreatic islets would be a promising therapy to treat diabetes. But, because of the limited supply of human donor islets, other cellular sources have to be considered. Stem cells characterized by extensive proliferation and differentiation capacity may be a valuable source for the in vitro generation of islets. Insulin-producing cells derived from embryonic stem (ES) cells have been shown to reverse experimentally induced diabetes in animal models. However, the oncogenic properties of ES cells are critical in the context of clinical applications and efficient cell-lineage selection systems need to be established. Future studies have to demonstrate whether somatic stem cells residing in adult tissues, such as bone marrow, pancreatic ducts, intestine or liver may provide alternatives to generate functional pancreatic endocrine cells.

Integrity signals

Registry

Crossref · 10.1016/j.jbiotec.2004.03.023

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several methods of differentiation of ES cells to hepatic and insulin-producing cells have been described, but determining the precise identity of these cells is problematic due to a lack of suitable markers.

    “While several methods of differentiation of ES cells to hepatic and insulin-producing cells have been described, determining the precise identity of these cells is problematic due to a lack of suitable markers [20-23].”

Cited by

Sorted by citations

Authors
Blyszczuk, P., & Wobus, A. M.
Affiliations
Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) (DE)
Corresponding author
Wobus, Anna M.
Venue
Journal of Biotechnology
Publisher
Elsevier BV
Published
2004-09
Volume
113
Issue
1-3
Pages
3-13
ISSN
0168-1656 (ISSN-L)
OpenAlex
W2093001054
Cited by
31
References
0
Citations by year
2015: 1 · 2014: 1 · 2013: 1
FWCI
7.23
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
stem cells, pancreatic differentiation, pancreatic islets, cell therapy, diabetes mellitus, embryonic stem cells, insulin-producing cells, adult stem cells, oncogenicity, islet regeneration
MeSH terms
Animals, Cell Differentiation, Diabetes Mellitus, Humans, Islets of Langerhans, Stem Cells, Stem Cell Transplantation, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review